Edition:
United Kingdom

Viking Therapeutics Inc (VKTX.OQ)

VKTX.OQ on NASDAQ Stock Exchange Capital Market

4.12USD
24 Apr 2018
Change (% chg)

-- (--)
Prev Close
$4.12
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
241,329
52-wk High
$7.34
52-wk Low
$0.88

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.137
Sep '17 0.00 -0.222
Jun '17 0.00 -0.214
Mar '17 0.00 -0.234
FY 2016 Dec '16 0.00 -0.183
Sep '16 0.00 -0.200
Jun '16 0.00 -0.216
Mar '16 0.00 -0.398
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 2 0.00 0.00 0.00 --
Quarter Ending Sep-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 0.00
Year Ending Dec-19 4 22.25 88.99 0.00 41.65
Earnings (per share)
Quarter Ending Jun-18 3 -0.13 -0.09 -0.19 -0.23
Quarter Ending Sep-18 3 -0.13 -0.11 -0.18 -0.24
Year Ending Dec-18 4 -0.48 -0.42 -0.60 -0.86
Year Ending Dec-19 4 -0.49 -0.43 -0.55 -0.30
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.02 32.74
P/E High - Last 5 Yrs. -- 293.16 45.72
P/E Low - Last 5 Yrs. -- 91.58 24.22
Beta -- 0.90 0.88
Price to Sales (TTM) -- 110.88 5.71
Price to Book (MRQ) 8.74 13.58 5.37
Price to Tangible Book (MRQ) 8.74 14.04 6.95
Price to Cash Flow (TTM) -- 71.40 23.32
% Owned Institutions 5.67 12.75 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.71 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 399.06 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 78.82 5.69
Sales - 5 Yr. Growth Rate -- 32.16 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 0.68 25.00 19.36
EPS (TTM) vs TTM 1 Yr. Ago 61.48 -- --
EPS - 5 Yr. Growth Rate -- 38.99 10.76
Capital Spending - 5 Yr. Growth Rate -- 40.29 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.19
Current Ratio (MRQ) 1.85 5.30 2.98
LT Debt to Equity (MRQ) 0.00 22.96 12.18
Total Debt to Equity (MRQ) 46.30 24.62 16.45
Interest Coverage (TTM) -10.88 -99.34 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.02 54.44
Gross Margin - 5 Yr. Avg. -- 51.13 52.20
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -574.72 10.96
Operating Margin (TTM) -- -718.49 4.73
Operating Margin - 5 Yr. Avg. -- -596.03 6.40
Pre-Tax Margin (TTM) -- -692.96 5.57
Pre-Tax Margin - 5 Yr. Avg. -- -599.39 6.81
Net Profit Margin (TTM) -- -694.19 1.87
Net Profit Margin - 5 Yr. Avg. -- -602.24 3.09
Effective Tax Rate (TTM) -- 22.62 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.21 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,625,667 846,830,423
Net Income/Employee (TTM) -- 2,971,219 99,616,130
Receivable Turnover (TTM) -- 20.16 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.00 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -108.58 -1.11 10.95
Return on Assets - 5 Yr. Avg. -- -0.57 12.31
Return on Investment (TTM) -183.94 1.58 14.38
Return on Investment - 5 Yr. Avg. -- 2.21 16.10
Return on Equity (TTM) -184.23 2.41 16.07
Return on Equity - 5 Yr. Avg. -- 3.09 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 75.42 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Viking Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 25.24%
# of Holders: 37
Total Shares Held: 12,856,569
3 Mo. Net Change: 3,585,252
# New Positions: 6
# Closed Positions: 1
# Increased Positions: 7
# Reduced Positions: 1
# Net Buyers: 6
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.